Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice

Life Sciences

Volumn 64, Issue 26, 1999, Pages 2463-2470

  Kim, Hack Seang ^a   Son, Young Rey ^a   Kim, Seung Hwan ^b  

^a Chungbuk National University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

5 hydroxytryptamine; Head twitch response; N methyl D aspartate; Nitric oxide; Nitric oxide synthase inhibitor

Indexed keywords

7 NITROINDAZOLE; ARGININE; DEXTROMETHORPHAN; DIZOCILPINE; LINSIDOMINE; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; SEROTONIN; SEROTONIN 2 RECEPTOR; TRIFLUOPERAZINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HEAD TWITCH; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARGININE; DEXTROMETHORPHAN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEAD MOVEMENTS; MALE; METHYLENE BLUE; MICE; MICE, INBRED ICR; MOLSIDOMINE; N-METHYLASPARTATE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PENICILLAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS;

ANIMALIA;

EID: 0033591466     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00203-9     Document Type: Article

References (26)

1. 1. C. Nathan and Q.W. Xie, Cell 78 915-918 (1994).
2. 2. F. Murad, Neurotransmission 2 1-4 (1994).
3. 3. D.T. Monaghan and C.W. Cotman, J. Neurosci. 5 2909-2919 (1985).
4. 4. D.S. Bredt and S.H. Snyder, Neuron 8 3-11 (1992).
5. 5. D.S. Bredt, P.M. Hwang and S.H. Snyder, Nature 347 768-770 (1990).
6. 6. D.S. Bredt and S.H. Snyder, Proc. Natl. Acad. Sci. USA 86 9030-9033 (1989).
7. 7. T.M. Dawson, V.L. Dawson and S.H. Snyder, Ann. Neurol. 32 297-311 (1992).
8. 8. J. Garthwaite, S.L. Charles and R. Chess-Williams, Nature 336 385-388 (1988).
9. 9. I. Lucki, M.S. Nobler and A. Frazer, J. Pharmacol. Exp. Ther. 228 133-139 (1984).
10. 10. G.M. Goodwin and A.R. Green, Br. J. Pharmacol. 84 743-753 (1985).
11. 11. D.G. Grahame-Smith, J. Neurochem. 18 1053-1066 (1971).
12. 12. A. Carreau, D. Duval, H. Poignet, B. Scatton, X. Vige and J.P. Nowicki, Eur. J. Pharmacol. 256 214-249 (1994).
13. 13. K. Elliott, N. Minami, Y.A. Kolesnikov, G.W. Pasternak and C.E. Inturrisi, Pain 56 69-75 (1994).
14. 14. M.F. Giorguieff, M.L. Kemel and J. Glowinski, Neurosci. Lett. 6 73-77 (1977).
15. 15. H.S. Kim, I.S. Park and W.K. Park, Life Sci. 63 2305-2311 (1998).
16. 16. L. Heimer, R.D. Switzer and G.W. van Hoesen, Trends Neurosci. 5 83-87 (1982).
17. 17. A.E. Kelly and L.C. Throne, Brain Res. Bull. 29 247-254 (1992).
18. 18. H.S. Kim, G.S. Rhee, J.Y. Jung, J.H. Lee, C.G. Jang and W.K. Park, Life Sci. 58 1397-1402 (1996).
19. 19. H.S. Kim, G.S. Rhee, S.K. Oh and W.K. Park, Behav. Brain Res. in press (1999).
20. 20. R. Dall'Ollio, A. Vaccheri, O. Gandolfi, P. Roncada and N. Montanaro, Pharmacol. Biochem. Behav. 31 941-944 (1989).
21. 21. J. Garthwaite, G. Garthwaite, R.M. Palmer and S. Moncada, Eur. J. Pharmacol. 172 413-416 (1989).
22. 22. A.M. Babey, Y. Kolensnikov, J. Cheng, C.E. Inturrisi, R.R. Trifilletti and G.W. Pasternak, Neuropharmacology 33 1463-1470 (1994).
23. 23. S.H. Snyder and D.S. Bredt, Sci. Am. 266 68-77 (1992).
24. 24. A. Sulpizio, P.J. Fowler and E. Macko, Life Sci. 22 1439-1446 (1978)
25. 25. A. Gibson, S. Mirzazadeh S, A.J. Hobbs and P.K. Moore, Br. J. Pharmacol. 99 602-606 (1990).
26. 26. J.S. Gillespie, X.R. Liu and W. Martin, Br. J. Pharmacol. 98 1080-1082 (1989).